<VariationArchive VariationID="565721" VariationName="NM_025137.4(SPG11):c.276_285del (p.Arg93fs)" VariationType="Deletion" Accession="VCV000565721" Version="17" RecordType="classified" NumberOfSubmissions="7" NumberOfSubmitters="7" DateLastUpdated="2024-05-08" DateCreated="2018-10-10" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="569412" VariationID="565721">
      <GeneList>
        <Gene Symbol="SPG11" FullName="SPG11 vesicle trafficking associated, spatacsin" GeneID="80208" HGNC_ID="HGNC:11226" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="44562696" stop="44663662" display_start="44562696" display_stop="44663662" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="44854893" stop="44955875" display_start="44854893" display_stop="44955875" Strand="-" />
          </Location>
          <OMIM>610844</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_025137.4(SPG11):c.276_285del (p.Arg93fs)</Name>
      <CanonicalSPDI>NC_000015.10:44660588:GCTGTTACGAG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="44660589" stop="44660598" display_start="44660589" display_stop="44660598" variantLength="10" positionVCF="44660588" referenceAlleleVCF="TGCTGTTACGA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="44952787" stop="44952796" display_start="44952787" display_stop="44952796" variantLength="10" positionVCF="44952786" referenceAlleleVCF="TGCTGTTACGA" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>R93fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.44660590_44660599del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.44660590_44660599del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.44952788_44952797del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.44952788_44952797del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008885.1" sequenceAccession="NG_008885" sequenceVersion="1" change="g.8081_8090del">
            <Expression>NG_008885.1:g.8081_8090del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001160227.2" sequenceAccession="NM_001160227" sequenceVersion="2" change="c.276_285del">
            <Expression>NM_001160227.2:c.276_285del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001153699.1" sequenceAccession="NP_001153699" sequenceVersion="1" change="p.Arg93fs">
            <Expression>NP_001153699.1:p.Arg93fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_025137.4" sequenceAccession="NM_025137" sequenceVersion="4" change="c.276_285del" MANESelect="true">
            <Expression>NM_025137.4:c.276_285del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_079413.3" sequenceAccession="NP_079413" sequenceVersion="3" change="p.Arg93fs">
            <Expression>NP_079413.3:p.Arg93fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_025137.3" sequenceAccession="NM_025137" sequenceVersion="3" change="c.276_285del">
            <Expression>NM_025137.3:c.276_285del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="747220413" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_025137.4(SPG11):c.276_285del (p.Arg93fs) AND Hereditary spastic paraplegia 11" Accession="RCV000685354" Version="10">
        <ClassifiedConditionList TraitSetID="295">
          <ClassifiedCondition DB="MedGen" ID="C1858479">Hereditary spastic paraplegia 11</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-11" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_025137.4(SPG11):c.276_285del (p.Arg93fs) AND not provided" Accession="RCV001784308" Version="6">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-05-18" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_025137.4(SPG11):c.276_285del (p.Arg93fs) AND Amyotrophic lateral sclerosis type 5" Accession="RCV003333097" Version="1">
        <ClassifiedConditionList TraitSetID="22812">
          <ClassifiedCondition DB="MedGen" ID="C1865864">Amyotrophic lateral sclerosis type 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_025137.4(SPG11):c.276_285del (p.Arg93fs) AND Inborn genetic diseases" Accession="RCV002440418" Version="2">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-03-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-11" NumberOfSubmissions="7" NumberOfSubmitters="7" DateCreated="2018-10-10" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19105190</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20110243</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22154821</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26556829</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27217339</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
          <TraitSet ID="295" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3739" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Spastic paraplegia 11</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary spastic paraplegia mental impairment and thin corpus callosum</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary spastic paraplegia 11</ElementValue>
                <XRef ID="MONDO:0011445" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, COMPLICATED, WITH THIN CORPUS CALLOSUM</ElementValue>
                <XRef Type="MIM" ID="604360" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, WITH MENTAL IMPAIRMENT AND THIN CORPUS CALLOSUM</ElementValue>
                <XRef Type="MIM" ID="604360" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spastic paraplegia,  mental retardation and thin corpus callosum</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Spastic paraplegia 11, autosomal recessive</ElementValue>
                <XRef ID="Spastic+paraplegia+11/6677" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nakamura Osame syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Autosomal recessive hereditary spastic paraplegia, mental impairment, and thin corpus callosum</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HSP-TCC</ElementValue>
                <XRef Type="MIM" ID="604360" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">SPG11</ElementValue>
                <XRef Type="MIM" ID="604360" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4919" />
                <XRef ID="4919" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Spastic paraplegia 11 (SPG11) is characterized by progressive spasticity and weakness of the lower limbs frequently associated with the following: mild intellectual disability with learning difficulties in childhood and/or progressive cognitive decline; peripheral neuropathy; pseudobulbar involvement; and increased reflexes in the upper limbs. Less frequent findings include: cerebellar signs (ataxia, nystagmus, saccadic pursuit); retinal degeneration; pes cavus; scoliosis; and parkinsonism with characteristic brain MRI features that include thinning of the corpus callosum. Onset occurs mainly during infancy or adolescence (range: age 1-31 years) and in rare cases as late as age 60 years. Most affected individuals become wheelchair bound one or two decades after disease onset.</Attribute>
                <XRef ID="NBK1210" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301389</ID>
                <ID Source="BookShelf">NBK1210</ID>
              </Citation>
              <XRef ID="2822" DB="Orphanet" />
              <XRef ID="C1858479" DB="MedGen" />
              <XRef ID="MONDO:0011445" DB="MONDO" />
              <XRef Type="MIM" ID="604360" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="22812" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="219" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Amyotrophic lateral sclerosis type 5</ElementValue>
                <XRef ID="MONDO:0011196" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">AMYOTROPHIC LATERAL SCLEROSIS 5, JUVENILE</ElementValue>
                <XRef Type="MIM" ID="602099" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610844.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610844.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610844.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610844.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610844.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="610844.0004" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ALS5</ElementValue>
                <XRef Type="MIM" ID="602099" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15343" />
                <XRef ID="15343" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10503" />
                <XRef ID="10503" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301623</ID>
                <ID Source="BookShelf">NBK1450</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2007">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_AmyotrophicLateralSclerosis.pdf</URL>
                <CitationText>Orphanet, Amyotrophic lateral sclerosis, 2007</CitationText>
              </Citation>
              <XRef ID="300605" DB="Orphanet" />
              <XRef ID="C1865864" DB="MedGen" />
              <XRef ID="MONDO:0011196" DB="MONDO" />
              <XRef Type="MIM" ID="602099" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1735351" SubmissionDate="2018-11-12" DateLastUpdated="2018-10-10" DateCreated="2018-10-10">
        <ClinVarSubmissionID localKey="15:44952787:G" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000886426" DateUpdated="2018-10-10" DateCreated="2018-10-10" Type="SCV" Version="1" SubmitterName="HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology" OrgID="505530" OrganizationCategory="laboratory" OrgAbbreviation="HA" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-07-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">15:44952787:G:H00007C</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">Confusion</ElementValue>
                </Name>
                <XRef DB="HP" ID="HP:0001289" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SPG11" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025137.3:c.276_285delTCGTAACAGC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604360" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>AGHI-WGS-HudsonAlpha</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB4782643</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5407060" SubmissionDate="2022-12-08" DateLastUpdated="2022-12-17" DateCreated="2022-12-17">
        <ClinVarSubmissionID localKey="NM_025137.4:c.276_285del|OMIM:604360" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002762904" DateUpdated="2022-12-17" DateCreated="2022-12-17" Type="SCV" Version="1" SubmitterName="Genome-Nilou Lab" OrgID="507598" OrganizationCategory="laboratory" OrgAbbreviation="Genome Nilou" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SPG11" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025137.4:c.276_285del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604360" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12366175</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5419184" SubmissionDate="2022-12-27" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="A18251|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002771251" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Athena Diagnostics" OrgID="1012" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">27217339</ID>
          </Citation>
          <Comment>This variant is expected to result in the loss of a functional protein. The frequency of this variant in the general population is consistent with pathogenicity (http://gnomad.broadinstitute.org). This variant has been identified in at least one individual tested at Athena Diagnostics with clinical features associated with this gene.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Athena Diagnostics Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">26467025</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025137.3:c.276_285del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12478070</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7562483" SubmissionDate="2023-10-02" DateLastUpdated="2023-10-07" DateCreated="2023-10-07">
        <ClinVarSubmissionID localKey="50535|OMIM:602099" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004040989" DateUpdated="2023-10-07" DateCreated="2023-10-07" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025137.4:c.276_285del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="602099" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13858665</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3963441" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="083cb20bc7858473dc0211959288c8fdd636c34cab4f9a03deae8d2000c44431|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002021922" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-12-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025137.3:c.276_285del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1584956" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2018-10-10">
        <ClinVarSubmissionID localKey="346222|MedGen:C1858479" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000812832" DateUpdated="2024-02-14" DateCreated="2018-10-10" Type="SCV" Version="7" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19105190</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20110243</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22154821</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26556829</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27217339</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Arg93Alafs*25) in the SPG11 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SPG11 are known to be pathogenic (PMID: 19105190, 20110243, 22154821, 26556829). This variant is present in population databases (rs747220413, gnomAD 0.007%). This premature translational stop signal has been observed in individual(s) with complex hereditary spastic paraplegia (PMID: 27217339). ClinVar contains an entry for this variant (Variation ID: 565721). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SPG11" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000015.9:g.44952787_44952796del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1858479" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5231752" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a509966|MedGen:C0950123" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002749064" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-03-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.276_285del10 pathogenic mutation (also known as p.R93Afs*25), located in coding exon 2 of the SPG11 gene, results from a deletion of 10 nucleotides at positions 276 to 285 causing a translational frameshift with a predicted alternate stop codon. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SPG11" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025137.3:c.276_285del10</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0950123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7562483" TraitType="Disease" MappingType="XRef" MappingValue="602099" MappingRef="OMIM">
        <MedGen CUI="C1865864" Name="Amyotrophic lateral sclerosis type 5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5231752" TraitType="Disease" MappingType="XRef" MappingValue="C0950123" MappingRef="MedGen">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5407060" TraitType="Disease" MappingType="XRef" MappingValue="604360" MappingRef="OMIM">
        <MedGen CUI="C1858479" Name="Hereditary spastic paraplegia 11" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5419184" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1735351" TraitType="Disease" MappingType="XRef" MappingValue="604360" MappingRef="OMIM">
        <MedGen CUI="C1858479" Name="Hereditary spastic paraplegia 11" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1735351" TraitType="Finding" MappingType="Name" MappingValue="Confusion" MappingRef="Preferred">
        <MedGen CUI="C0009676" Name="Confusion" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3963441" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1584956" TraitType="Disease" MappingType="XRef" MappingValue="C1858479" MappingRef="MedGen">
        <MedGen CUI="C1858479" Name="Hereditary spastic paraplegia 11" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

